FDA Inspection
Northern Biomedical Research, Inc.Northern Biomedical Research, Inc. – FDA Inspection, Mar 29, 2024
Record Details
This FDA Inspection record concerns Northern Biomedical Research, Inc., with an inspection on March 29, 2024, issued by the Detroit District Office, covering biologics.
View Company Profile
ID · 01068844-f690-42c0-ad62-cd2bcdb5bea5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1234502
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 58.130(c)Conduct: identification of test specimens
- 21 CFR 58.185(a)(9)Final report: circumstances affecting data qual., integrity
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Northern Biomedical Research, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| July 31, 2026 | Not classified | Detroit District Office | Bioresearch Monitoring |
Other documents for Northern Biomedical Research, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.